<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/1535</identifier>
				<datestamp>2021-08-28T02:17:43Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Serum antibody response in calves receiving modified live and/or inactivated vaccines containing bovine herpesvirus-1, bovine viral diarrhea virus, parainfluenza-3 virus, and bovine respiratory syncytial virus immunogens</dc:title>
	<dc:creator xml:lang="en">Fulton, Robert W.</dc:creator>
	<dc:creator xml:lang="en">Burge, Lurinda J.</dc:creator>
	<dc:creator xml:lang="en">d'Offay, J. M.</dc:creator>
	<dc:creator xml:lang="en">Payton, Mark E.</dc:creator>
	<dc:subject xml:lang="en">antibodies</dc:subject>
	<dc:subject xml:lang="en">antibody formation</dc:subject>
	<dc:subject xml:lang="en">antigens</dc:subject>
	<dc:subject xml:lang="en">calves</dc:subject>
	<dc:subject xml:lang="en">immune response</dc:subject>
	<dc:subject xml:lang="en">immunization</dc:subject>
	<dc:subject xml:lang="en">inactivated vaccines</dc:subject>
	<dc:subject xml:lang="en">live vaccines</dc:subject>
	<dc:subject xml:lang="en">mucosal disease</dc:subject>
	<dc:subject xml:lang="en">serology</dc:subject>
	<dc:subject xml:lang="en">young animals</dc:subject>
	<dc:description xml:lang="en">Serum antibody responses to bovine herpesvirus-1 (BHV-1) bovine viral diarrhea virus (BVDV), parainfluenza-3 virus (PI-3V), and bovine respiratory syncytial virus (BRSV) by calves receiving viral vaccines were evaluated. Calves were vaccinated at day 0 with one of four commercial vaccines containing BHV-1, BVDV, PI-3V, and BRSV immunogens. Selected vaccines were given a second time at day 28. Calves were revaccinated at day 140 with the respective vaccine given at day 0. The vaccines contained modified live virus (MLV) and/ or inactivated components. Serums were collected at day 0 and at various intervals through day 196, and assayed for viral neutralizing antibodies. Between various vaccine groups there were differences in onset and duration of serum antibodies to each immunogen postvaccination. Anamnestic responses after day 140 revaccination to some but not all viruses were sometimes dependent on the type vaccine and level of antibodies at revaccination.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>1997-05-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/1535</dc:identifier>
	<dc:identifier>10.21423/bovine-vol1997no31.2p90-96</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; No. 31.2 (1997 May); 90-96</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/1535/1528</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 1997 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
